期刊文献+

眼科病理学发展与精准医学 被引量:7

Development of ophthalmic pathology and precision medicine
原文传递
导出
摘要 眼科病理学作为不可缺少的专业,在眼科学的发展中发挥着重要作用.随着全球范围对精准医学的关注和推广以及当今现代医学检测技术的快速发展,病理学发展面临着生存挑战和发展机遇.通过论述病理学发展与精准医学的关系,说明精准的病理学诊断是实施精准医学的基础.眼科病理学工作者应将提高眼部疾病病理学诊断的精准性放在首位,以期病理学诊断在未来的眼科精准医学中发挥更大的作用. As an indispensable professional,ophthalmic pathology plays an important role in the development of the ophthalmology.With the worldwide attention and promotion of precision medicine and the rapid development of modern medical testing technology,the development of pathology is facing the challenges of survival and development opportunities.We discuss the relationship between the development of pathology and the precision medicine to explain that the precise pathological diagnosis is the basis of the implementation of precision medicine.Ophthalmic pathology workers should be the first to improve the accuracy of the diagnosis of ocular diseases,in order to play a greater role in the future of precision medicine in the diagnosis of pathology.
作者 李永平 李彬
出处 《中华眼科杂志》 CAS CSCD 北大核心 2016年第10期724-727,共4页 Chinese Journal of Ophthalmology
关键词 诊断技术 眼科 石蜡包埋 活组织检查 免疫组织化学 精准医疗 Diagnostic techniques,ophthalmological Paraffin embedding Biopsy Immunohistochemistry Precision medicine
  • 相关文献

参考文献22

二级参考文献107

  • 1赵晓航,钱阳明.生物样本库——个体化医学的基础[J].转化医学杂志,2014,3(2):69-73. 被引量:23
  • 2李彬,孙宪丽.眼科病理检查标本的获取和送检[J].中华眼科杂志,2005,41(10):955-956. 被引量:5
  • 3Harbour JW. Molecular prognostic testing in uveal melanoma: has it finally come of age? Arch Ophthalmol,2007,125 : 1122-1123.
  • 4Diener-West M, Reynolds SM, Agugliaro D J, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol,2005,123 : 1639- 1643.
  • 5Bedikian AY. Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin,2006,46 : 151-166.
  • 6Flaherty LE, Unger JM, Liu PY, et al. Metastatic melanoma from intraocular primary tumors: the Southwest Oneology Group experience in phase Ⅱ advanced melanoma clinical trials. Am J Clin Oncol, 1998,21:568-572.
  • 7Yang H, Grossniklaus HE. Combined immunologic and anti- angiogenic therapy reduces hepatic micrometastases in a murine ocular melanoma model. Curt Eye Res, 2006.31:557-562.
  • 8Peters S, Voelter V, Zografos L, et al. Intraarterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol,2006,17:578- 583.
  • 9Egan KM, Seddon JM, Glynn RJ, et al. Epidemiologie aspects of uveal melanoma. Surv Ophthalmol, 1988,32:239-251.
  • 10Hu DN, Yu G, McCormick SA, et al. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol,2008 ,145 :418-423.

共引文献254

同被引文献80

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部